Iron status and the outcome of HIV infection: an overview
- 2 February 2001
- journal article
- review article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 20 (3) , 111-115
- https://doi.org/10.1016/s1386-6532(00)00134-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Bone marrow macrophage iron grade and survival of HIV-seropositive patientsAIDS, 1999
- Haptoglobin polymorphism, iron metabolism and mortality in HIV infectionAIDS, 1998
- Randomization to Iron Supplementation of Patients with Advanced Human Immunodeficiency Virus Disease--An Inadvertent but Controlled Study with Results Important for Patient CareThe Journal of Infectious Diseases, 1996
- Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites.The Journal of Experimental Medicine, 1995
- A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1995
- Dose of desferrioxamine and evolution of HIV‐1 infection in thalassaemic patientsBritish Journal of Haematology, 1994
- Progress in understanding the pathogenesis of the anemia of chronic disease [see comments]Blood, 1992
- Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila.Journal of Clinical Investigation, 1991
- Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity.The Journal of Experimental Medicine, 1991
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.The Journal of Experimental Medicine, 1984